4-Butyl-4'-((4-butyl-2,6-difluorophenyl)ethynyl)-1,1'-biphenyl, 98%, 100mg

6-Chloro-3-methoxypyridin-2-amine, 97%, 100mg

4-Cyano-4'-butylbiphenyl, 98.0%, 25g

2-Chloro-4-methyl-nicotinic acid, 95.0%, 1g

5-(4-Chlorophenyl)thiazol-2-amine, 95.0%, 25g

n-Octane>97.0%(GC)500mL

2-(1-(Tert-butoxycarbonyl)pyrrolidine-2-carboxamido)-[1,1'-biphenyl]-4,4'-dicarboxylic acid, 98%, 100mg

4,4,5,5-Tetramethyl-2-(2-methylprop-1-en-1-yl)-1,3,2-dioxaborolane, 95.0%, 1g

4-Methoxyphenyl acetate, 95.0%, 250mg

2-(2,4-Dichlorophenyl)acetamide, 98.0%, 1g

2-(2-Hydroxyphenyl)-4H-benzo[e][1,3]oxazin-4-one, 98%, 500g

(S)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione (Linagliptin Impurity), 97%, 50mg

4-Nitrophenyl 2-(((benzyloxy)carbonyl)amino)acetate, 95.0%, 500g